About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Maryland | 690 Studies

Clinical Trials Prostate CancerMaryland

Prostate Cancer Clinical Trials in Maryland

Find 690 clinical trials for prostate cancer near Maryland. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 501-520 of 690 trials

WithdrawnHealth Interventions in Men Undergoing Radical ProstatectomyThe goal of the study is to assess the impact of a health intervention, involving both diet and exercise modification, on outcomes following radical prostatectomy for the…NCT01748110·Baltimore, Maryland CompletedStudy to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate CancerThe purpose of the study is to determine whether lenalidomide is safe and effective for use in combination with docetaxel and prednisone for the treatment of subjects with…NCT00988208·Phoenix, Arizona and 209 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedIpatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate CancerThe purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of ipatasertib plus abiraterone and prednisone/prednisolone compared with placebo plus…NCT03072238·Chandler, Arizona and 175 others

CompletedPReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2Approximately one million transrectal prostate biopsies are performed annually in the U.S., and the risk of post- biopsy infection is increasing due to greater antibiotic…NCT04815876·Los Angeles, California and 15 others

CompletedA Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.The purpose of the study is to assess if the addition of darolutamide to ADT compared with ADT alone would result in superior clinical efficacy in participants with metastatic…NCT05059236·Homewood, Alabama and 30 others

RecruitingWATER IV PCa (AS Sub-study)The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate…NCT07650448·Chandler, Arizona and 27 others

CompletedVaccine and Antibody Treatment of Prostate CancerThis study will evaluate the side effects of a fixed dose of vaccine and GM-CSF with increasing doses of anti-CTLA-4 antibody in patients with advanced prostate cancer.NCT00113984·Bethesda, Maryland

TerminatedA Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate CancerThe purpose of this study is to assess the safety, efficacy, tolerability, and toxicity of docetaxel alone, in combination with BMS-986218, or in combination with nivolumab plus…NCT05169684·Tucson, Arizona and 30 others

CompletedCombination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00005810·San Francisco, California and 6 others

CompletedA Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)The main purpose of this study is to establish a recommended dose of Alpharadin to be used in combination with docetaxel in patients with bone metastases from castration-resistant…NCT01106352·San Francisco, California and 6 others

CompletedGadoxetate Enhanced Imaging Study to Detect Prostate CancerBackground: \- Prostate cancer is the most common cancer type among men. Some prostate cancers respond to hormonal therapy.NCT01867424·Bethesda, Maryland

CompletedEfficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate CancerThis open-label, multicenter, Phase 2 trial, will assess the anti tumor activity, safety and pharmacokinetics, of Panzem® NCD in patients with metastatic, docetaxel refractory…NCT00394810·Indianapolis, Indiana and 3 others

CompletedStudy of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate CancerProtocol G200712 is a Phase II, exploratory study to assess the effects of GTx-758 on serum prostate specific antigen (PSA) response ans serum PSA progression in men with…NCT01615120·Burbank, California and 25 others

TerminatedA Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsStudy CP-MGC018-03 is an open-label, two-part, Phase 2 study.NCT05551117·Fountain Valley, California and 62 others

TerminatedValproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate CancerRATIONALE: Valproic acid may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00670046·Baltimore, Maryland

Active not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid TumorsThis is a Phase 1, open-label, dose-escalation and expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary antitumor activity, and effect on…NCT03845166·Duarte, California and 85 others

Active not recruitingTesting the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone MetastasisThis phase I/II trial studies the best dose and side effects of olaparib and how well it works with radium Ra 223 dichloride in treating patients with castration-resistant…NCT03317392·La Jolla, California and 21 others

CompletedFamilial Prostate CancerThe purpose of this study is to identify affected individuals in families with prostate cancer and to use this information to identify genetic markers closely-linked to the…NCT00001377·Bethesda, Maryland

TerminatedAn Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate CancerThis Phase 2 Open-label Study examines the efficacy, safety, tolerability, and pharmacokinetics (PK) of tomivosertib (eFT508) in Patients with advanced CRPC.NCT03690141·New Haven, Connecticut and 9 others

CompletedSafety Study of Hemospan® in Prostatectomy PatientsThis is a progressive dose escalation study designed to evaluate the safety of Hemospan compared to a standard crystalloid solution (Ringer's lactate) in elective surgery patients…NCT00425334·Baltimore, Maryland

PreviousPage 26 of 35Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma